Mango Allergy: Peel Urushiol, Oral Allergy Syndrome, or True IgE?

Yes. Mango peel contact dermatitis and poison ivy contact dermatitis share the same urushiol allergen chemistry, but sensitization develops independently through separate exposures. Many patients have mango peel dermatitis without prior poison ivy exposure — they became sensitized through repeated mango peeling. Conversely, someone allergic to poison ivy may or may not react to mango peel: studies estimate that 30–50% of poison ivy-sensitive individuals will cross-react to mango peel urushiol. The reactions are clinically identical in appearance and mechanism, but sensitization history and exposure route determine whether both are present in any individual patient.

The answer depends completely on which type you have. For urushiol contact dermatitis from handling mango peel, avoid handling raw cashew shells and lacquer products, which share urushiol chemistry — but you can eat cashew nuts safely as sold, since processing removes urushiol. For OAS from birch pollen cross-reactivity, other Bet v 1-containing foods may trigger mouth tingling: apple, pear, cherry, peach, hazelnut, carrot, and celery. For OAS from grass pollen profilins, tomato, orange, celery, and melon may also cause symptoms. For LTP sensitization, your allergist should conduct a full food challenge panel, as the heat-stable LTP protein family has a broader cross-reactive range.

Stomach pain after eating mango — a very common search query — most likely reflects one of two things. First, OAS extending to the GI tract: the same cross-reactive pollen proteins that cause mouth tingling can trigger cramps and nausea when larger amounts of mango are consumed, as the proteins interact with mast cells lining the gut. Second, histamine intolerance: mango is a moderate histamine liberator, meaning it triggers endogenous histamine release from mast cells in the gut. Patients with diamine oxidase (DAO) enzyme deficiency accumulate histamine from both the mango itself and the triggered release, causing dose-dependent GI symptoms. Both mechanisms produce negative conventional IgE allergy tests. A food diary correlating symptoms with quantity consumed and cooking method can help distinguish which is operating.

For most OAS patients, yes — cooking mango is the practical solution. The birch and grass pollen cross-reactive proteins in mango (Bet v 1 homologs and profilins) are heat-labile and denature when heated to approximately 60–70°C, so baked mango, canned mango, mango in cooked chutneys, and mango in hot curry dishes are typically well tolerated. The critical exception is LTP-mediated sensitization: LTP proteins are heat-stable and survive cooking, so patients who react to cooked mango with systemic symptoms may have LTP involvement and need allergist evaluation. If you are unsure which pathway applies to you, have an allergist conduct component-resolved allergy testing before self-testing with cooked preparations.

Not for the typical cashew nut allergy. Commercial cashew allergy (Ana o 3, the 2S albumin storage protein) is an IgE-mediated reaction to the nut proteins inside the shell — completely different from the urushiol in cashew shell oil. Cashew nut protein IgE does NOT predict mango flesh allergy. The Anacardiaceae family cross-reactivity relevant to mango is PEEL contact dermatitis via urushiol, not a food protein IgE response. So if you are allergic to cashew nuts, you do not automatically have higher risk for mango flesh reactions. You may, however, develop contact dermatitis from handling mango peel if you are also sensitized to cashew shell oil urushiol — but this is contact dermatitis, not the nut allergy pathway. Most cashew-allergic patients eat mango flesh without issue.

Not in the immunological sense. The most common mango rash — perioral blistering 24–48 hours after peeling — is a Type IV delayed T-cell hypersensitivity reaction to urushiol, which is technically a contact allergy but operates through a completely different mechanism from IgE-mediated food allergy. It involves no mast cells, no histamine, and no IgE antibodies. Antihistamines will not treat it. A second non-IgE rash can occur from direct contact with mango acid around the mouth, particularly in children with sensitive skin — this is chemical irritation, not an immune reaction at all. True IgE-mediated mango allergy producing urticaria (hives) is rare. Having an allergist determine which type of rash you are experiencing changes the management completely.

Yes, both main pathways can develop in adulthood. Urushiol contact dermatitis commonly develops after repeated exposures over months or years — individuals who begin cooking with fresh mango regularly may develop sensitivity after multiple peel-handling episodes without prior reaction, as T-cell sensitization builds with cumulative exposure. OAS from pollen cross-reactivity typically emerges during or after pollen allergy onset, which can occur at any age. Adult-onset food allergy overall accounts for roughly 48% of all food-allergic adults per JAMA Network Open data, and OAS-type reactions from newly developing pollen allergies are among the most common new food sensitivities in adults. LTP sensitization can also develop in adulthood, particularly in patients who relocate to regions with different pollen exposures.

Both conditions cause skin reactions attributed to fruit handling, but through entirely different mechanisms. Mango peel dermatitis is a true immunological reaction — a Type IV T-cell delayed hypersensitivity to urushiol, involving memory T-cells, cytokine cascades, and cellular inflammation. It can occur in any lighting condition and requires prior sensitization. Lime phytophotodermatitis is a photochemical burn — furocoumarins in lime juice absorb UVA radiation and damage skin cells through DNA cross-linking, with absolutely no immune activation, no mast cells, no T-cells. It requires sun exposure after lime juice contact and occurs on first exposure without prior sensitization. Both produce blistering reactions, but the treatment, timing, and prevention strategies are completely different: urushiol dermatitis requires avoiding the fruit; phytophotodermatitis requires only avoiding sun exposure after lime contact.

Evidence from multiple clinical trials suggests yes. Subcutaneous immunotherapy (allergy shots) and sublingual immunotherapy (SLIT drops) targeting birch pollen have been shown to reduce not only seasonal nasal and ocular symptoms but also OAS severity from Bet v 1-cross-reactive foods including apple, cherry, hazelnut, and by extension other PR-10-containing foods like mango flesh. The mechanism is reduction in birch-specific IgE and induction of IgG4 blocking antibodies that compete with IgE for allergen binding, lowering the reactivity threshold for cross-reactive food proteins. Studies suggest meaningful improvement in OAS symptoms occurs within 1–2 years of immunotherapy, with fuller benefit at 3–5 years. The same logic applies to grass pollen immunotherapy for profilin-driven mango OAS.

The need for epinephrine depends on your specific mechanism and history. For pure urushiol contact dermatitis (peel, delayed reaction), epinephrine is not indicated — this is a non-IgE reaction that does not cause anaphylaxis. For mild OAS from mango flesh, most allergists do not routinely prescribe epinephrine for localized oral symptoms, though symptoms extending beyond the mouth (throat tightening, generalized hives, GI cramping, dizziness) change that calculus. For any history of systemic reaction to mango — hives spreading beyond the mouth, difficulty breathing, throat swelling, or cardiovascular symptoms — epinephrine prescription is warranted and recommended by the AAAAI. If you are unsure whether your past mango reactions were systemic, a board-certified allergist can review your history and determine whether epinephrine is appropriate. Do not assume mild past reactions will always remain mild.